Back

A new model for predicting cardiovascular events in hypertrophic cardiomyopathy: the role of systemic inflammation

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease 2 Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ines Miranda

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

6 More presentations in this session

Presentation thumbnail
Apical hypertrophic cardiomyopathy: is it truly a rare variant?
Doctor I. Martins Moreira (Vila Real, PT)
Abstract Slides Video
Presentation thumbnail
Hypertrophic cardiomyopathy and coronary artery disease: prevalence, characteristics, and implications in the context of evolving physical exercise recommendations
Doctor I. Ferreira Neves (Lisboa, PT)
Abstract Slides Video
Presentation thumbnail
Sex differences in hypertrophic cardiomyopathy
Doctor M. Bernardo (Vila Real, PT)
Abstract Slides Video
Presentation thumbnail
Hypertrophic cardiomyopathy in a tertiary care center, a descriptive study
Doctor M. Dankova (Bratislava, SK)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of mavacamten therapy in hypertrophic cardiomyopathy: An up-to-date systematic review and meta-analysis
Doctor M. Yacoub (Dublin, IE)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in myocardial disease 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Hypertrophic cardiomyopathy phenotype and the importance of systemic inflammation
thumbnail
Congress Presentation
One-year outcomes of patients with hypertrophic cardiomyopathy according to levels of inflammatory biomarkers
thumbnail
Congress Presentation
Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources